{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:45:31Z","timestamp":1784241931008,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.carrev.2021.06.016","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:21:18Z","timestamp":1624072878000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Brian C.","family":"Case","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Torguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2021.06.016_bb0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.carrev.2021.06.016_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1358863X07079823","article-title":"Current state of endovascular treatment of femoro-popliteal artery disease","volume":"12","author":"Zeller","year":"2007","journal-title":"Vasc. Med."},{"key":"10.1016\/j.carrev.2021.06.016_bb0015","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jcin.2017.12.012","article-title":"Disease burden and clinical outcomes following initial diagnosis of critical limb ischemia in the Medicare population","volume":"11","author":"Mustapha","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.06.016_bb0020","first-page":"1047","article-title":"Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease","volume":"76","author":"Schmidt","year":"2010","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.carrev.2021.06.016_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-5-14","article-title":"The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database","volume":"5","author":"Caro","year":"2005","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.carrev.2021.06.016_bb0030","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1253\/circj.CJ-18-0014","article-title":"Design strategies for global clinical trials of endovascular devices for critical limb ischemia (CLI)- a joint USA-Japanese perspective","volume":"82","author":"Yokoi","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.carrev.2021.06.016_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1534734619884438","article-title":"Limb salvage in diabetic patients with ischemic heel ulcers","volume":"19","author":"Meloni","year":"2020","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.carrev.2021.06.016_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tcm.2019.04.002","article-title":"Lower extremity critical limb ischemia: a review of clinical features and management","volume":"30","author":"Levin","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.carrev.2021.06.016_bb0045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jcin.2016.02.014","article-title":"1-Year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-long study","volume":"9","author":"Micari","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.06.016_bb0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2019.12.012","article-title":"Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: insights from the Food and Drug Administration 2019 circulatory system devices panel meeting on late mortality","volume":"222","author":"Dan","year":"2020","journal-title":"Am. Heart J."}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892100316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383892100316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:21:05Z","timestamp":1761560465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383892100316X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":10,"alternative-id":["S155383892100316X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.06.016","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}